Cambium Oncology is a pre-clinical start-up focused on developing company.
Cambium Oncology has raised $5.0M in total funding. The most recent round was Seed. The last funding was announced in January 2025.
Cambium Oncology's investors include Orient Europharma Co.
Cambium Oncology is headquartered in Atlanta, United States.
Cambium Oncology is a pre-clinical start-up focused on developing company.
Cambium Oncology is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Cambium Oncology — Funding & Investors." VCBacked, January 13, 2025, https://www.vcbacked.co/company/cambium-oncology. Accessed August 14, 2026.
VCBacked. (2025). Cambium Oncology — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/cambium-oncology
{{cite web |title=Cambium Oncology — Funding & Investors |url=https://www.vcbacked.co/company/cambium-oncology |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated